Opendata, web and dolomites

PLATOSCIENCE SIGNED

Personalized Neurostimulation Approach for the Treatment of Depression

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PLATOSCIENCE project word cloud

Explore the words cloud of the PLATOSCIENCE project. It provides you a very rough idea of what is the project "PLATOSCIENCE" about.

50    analytics    patent    consists    measuring    standard    health    stimulation    platocure    acknowledge    world    group    medical    2005    ph    yields    clinics    headset    2015    tracked    qualified    techniques    introduction    solutions    competition    electrophysiological    yielding    commercialisation    electrodes    revenue    worldwide    efficient    cloud    depressions    stakeholders    15    clinical    300    device    untreated    international    treatment    nor    personalised    patient    depression    cognitive    million    programmable    plug    ph1    benefits    data    establishing    portable    despite    platoscience    patients    strategy    moderate    tdcs    clear    neuroimaging    commercialization    eeg    start    170bn    neurostimulation    segment    rehabilitation    electroencephalogram    cranial    hereafter    app    jobs    25    setting    connected    professionals    direct    first    market    collection    people    customized    trans    home    2026    validation    advantage    online    sme    falling    severe    predictive    costing    medication    gross    18    conventional    profit    acute    individual    until    create    regulatory    subject    protected    cumulative    relevance    options    hospitals    play   

Project "PLATOSCIENCE" data sheet

The following table provides information about the project.

Coordinator
PLATOSCIENCE APS 

Organization address
address: VESTERBROGADE 26
city: KOBENHAVN
postcode: 1620
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Project website https://platoscience.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PLATOSCIENCE APS DK (KOBENHAVN) coordinator 50˙000.00

Map

 Project objective

Depression currently affects more than 300 million people worldwide, that is an increase of over 18% between 2005 and 2015. Moreover, 50% of major depressions are untreated in Europe, costing about €170Bn per year. Despite subject´s relevance, there are not any efficient nor customized treatment options, these falling often within conventional solutions (e.g. cognitive techniques), medication or neurostimulation techniques that do not acknowledge an individual rehabilitation for the patient.

Platoscience has developed the world’s first plug n’ play device based on trans-cranial direct current neurostimulation (tDCS) for a personalised at-home treatment of depression. The patent-protected device, PlatoCure, consists of a portable neurostimulation headset with two programmable electrodes, easy to use and control, connected to an app to be tracked by health professionals and for cloud data collection and predictive analytics to improve individual treatment. PlatoCure also includes online neuroimaging by electroencephalogram (EEG) that enables measuring of electrophysiological data during stimulation. This yields a significant advantage of PlatoCure against competition, strengthening market introduction to become the standard treatment device for moderate to severe depression, yielding benefits for a large group of stakeholders, including patients, medical professionals, hospitals and clinics.

The SME Ph1 will be crucial for: i) establishing partnerships with relevant stakeholders on an international level in the medical segment, ii) setting up a regulatory strategy and iii) developing a clear commercialisation strategy. Hereafter, PlatoScience will be able to start SME Ph 2 focusing on the clinical validation of the device with hospitals and clinics. Until the end of 2026, we expect a cumulative revenue of €10,1 million, gross profit of €8,25 million and to create 15 qualified new jobs, within 5 years of commercialization.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PLATOSCIENCE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PLATOSCIENCE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

SmartDegrees (2020)

First anti-fraud plataform for the registration and certification of diplomas and academic certificates based in blockchain

Read More  

GREEN WHS (2019)

NATURE FRIENDLY WATER HYDRAULIC STEERING SYSTEM

Read More